A COVID-19 vaccine developed by the University of Oxford appears safe and triggers an immune response, reports new Lancet randomised controlled trial (20 July 2020) with 1,0770 participants. The adenovirus-vectored vaccine led to them making antibodies and T-cells that can fight the coronavirus.
No comments:
Post a Comment